» Authors » Brandon D Lowery

Brandon D Lowery

Explore the profile of Brandon D Lowery including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 102
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Henry A, Mo X, Finan C, Chaffin M, Speed D, Issa H, et al.
Nat Genet . 2025 Mar; PMID: 40038546
Heart failure (HF) is a major contributor to global morbidity and mortality. While distinct clinical subtypes, defined by etiology and left ventricular ejection fraction, are well recognized, their genetic determinants...
2.
Zheng S, Henry A, Cannie D, Lee M, Miller D, McGurk K, et al.
Nat Genet . 2024 Nov; 56(12):2646-2658. PMID: 39572783
Dilated cardiomyopathy (DCM) is a leading cause of heart failure and cardiac transplantation. We report a genome-wide association study and multi-trait analysis of DCM (14,256 cases) and three left ventricular...
3.
Davogustto G, Zhao S, Li Y, Farber-Eger E, Lowery B, Shaffer L, et al.
medRxiv . 2024 Feb; PMID: 38405916
Background: Atrial Fibrillation (AF) is a common and clinically heterogeneous arrythmia. Machine learning (ML) algorithms can define data-driven disease subtypes in an unbiased fashion, but whether the AF subgroups defined...
4.
Amancherla K, Schlendorf K, Vlasschaert C, Lowery B, Wells Q, See S, et al.
J Card Fail . 2024 Feb; 30(6):848-852. PMID: 38367904
No abstract available.
5.
Amancherla K, Schlendorf K, Vlasschaert C, Lowery B, Wells Q, See S, et al.
Am J Transplant . 2023 May; 23(8):1256-1263. PMID: 37156299
Cardiac allograft vasculopathy (CAV) is a leading cause of late graft failure and mortality after heart transplantation (HT). Sharing some features with atherosclerosis, CAV results in diffuse narrowing of the...
6.
Vaitinadin N, Shi M, Shaffer C, Farber-Eger E, Lowery B, Agrawal V, et al.
J Am Heart Assoc . 2022 Jun; 11(11):e025578. PMID: 35656995
Background Early (grade 1) cardiac left ventricular diastolic dysfunction (G1DD) increases the risk for heart failure with preserved ejection fraction and may improve with aggressive risk factor modification. Type 2...
7.
Schuler K, Hemnes A, Annis J, Farber-Eger E, Lowery B, Halliday S, et al.
Respir Res . 2022 Jun; 23(1):138. PMID: 35643554
Background: Study of pulmonary arterial hypertension (PAH) in claims-based (CB) cohorts may facilitate understanding of disease epidemiology, however previous CB algorithms to identify PAH have had limited test characteristics. We...
8.
Wada Y, Yang T, Shaffer C, Daniel L, Glazer A, Davogustto G, et al.
Circulation . 2022 Jan; 145(4):299-308. PMID: 34994586
Background: Multiple reports associate the cardiac sodium channel gene () variants S1103Y and R1193Q with type 3 congenital long QT syndrome and drug-induced long QT syndrome. These variants are too...
9.
Davogustto G, Clark D, Hardison E, Yanis A, Lowery B, Halasa N, et al.
JAMA Netw Open . 2021 May; 4(5):e2110323. PMID: 34009351
No abstract available.
10.
Ahlers M, Lowery B, Farber-Eger E, Wang T, Bradham W, Ormseth M, et al.
J Am Heart Assoc . 2020 May; 9(10):e014661. PMID: 32378457
Background Inflammation may contribute to incident heart failure (HF). Rheumatoid arthritis (RA), a prototypic inflammatory condition, may serve as a model for understanding inflammation-related HF risk. Methods and Results Using...